These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35083761)

  • 21. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant.
    Tian D; Sun Y; Xu H; Ye Q
    J Med Virol; 2022 Jun; 94(6):2376-2383. PubMed ID: 35118687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies.
    Dhama K; Nainu F; Frediansyah A; Yatoo MI; Mohapatra RK; Chakraborty S; Zhou H; Islam MR; Mamada SS; Kusuma HI; Rabaan AA; Alhumaid S; Mutair AA; Iqhrammullah M; Al-Tawfiq JA; Mohaini MA; Alsalman AJ; Tuli HS; Chakraborty C; Harapan H
    J Infect Public Health; 2023 Jan; 16(1):4-14. PubMed ID: 36446204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in the infection fatality rate of Omicron variant compared with previous variants in South Africa.
    Liu Y; Yu Y; Zhao Y; He D
    Int J Infect Dis; 2022 Jul; 120():146-149. PubMed ID: 35462038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population Immunity and Covid-19 Severity with Omicron Variant in South Africa.
    Madhi SA; Kwatra G; Myers JE; Jassat W; Dhar N; Mukendi CK; Nana AJ; Blumberg L; Welch R; Ngorima-Mabhena N; Mutevedzi PC
    N Engl J Med; 2022 Apr; 386(14):1314-1326. PubMed ID: 35196424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is Omicron the last SARS-CoV-2 Variant of Concern?
    Rahimi F; Talebi Bezmin Abadi A
    Arch Med Res; 2022 Apr; 53(3):336-338. PubMed ID: 35093242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
    Wolter N; Jassat W; Walaza S; Welch R; Moultrie H; Groome M; Amoako DG; Everatt J; Bhiman JN; Scheepers C; Tebeila N; Chiwandire N; du Plessis M; Govender N; Ismail A; Glass A; Mlisana K; Stevens W; Treurnicht FK; Makatini Z; Hsiao NY; Parboosing R; Wadula J; Hussey H; Davies MA; Boulle A; von Gottberg A; Cohen C
    Lancet; 2022 Jan; 399(10323):437-446. PubMed ID: 35065011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative instantaneous reproduction number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark.
    Ito K; Piantham C; Nishiura H
    J Med Virol; 2022 May; 94(5):2265-2268. PubMed ID: 34967453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Worldwide vaccine inequality threatens to unleash the next COVID-19 variant.
    Oehler RL; Vega VR
    Int J Infect Dis; 2022 Oct; 123():133-135. PubMed ID: 35988865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review.
    Kannan S; Shaik Syed Ali P; Sheeza A
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8019-8022. PubMed ID: 34982466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 outbreak trends in South Africa: A comparison of Omicron (B.1.1.529), Delta (B.1.617.2), and Beta (B.1.351) variants outbreak periods.
    Al Hasan SM; Saulam J; Mikami F; Kanda K; Yokoi H; Hirao T
    J Infect Public Health; 2022 Jul; 15(7):726-733. PubMed ID: 35687982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.
    Jassat W; Abdool Karim SS; Mudara C; Welch R; Ozougwu L; Groome MJ; Govender N; von Gottberg A; Wolter N; Wolmarans M; Rousseau P; ; Blumberg L; Cohen C
    Lancet Glob Health; 2022 Jul; 10(7):e961-e969. PubMed ID: 35597249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on omicron variant: What we know so far.
    Choudhary G; Prajapat M; Kumaravel J; Prabha PK; Sarma P; Handa V; Kaur H; Patel AP; Medhi B
    Indian J Pharmacol; 2022; 54(1):41-45. PubMed ID: 35343206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
    Dhawan M; Saied AA; Mitra S; Alhumaydhi FA; Emran TB; Wilairatana P
    Biomed Pharmacother; 2022 Oct; 154():113522. PubMed ID: 36030585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive review on Covid-19 Omicron (B.1.1.529) variant.
    Manjunath R; Gaonkar SL; Saleh EAM; Husain K
    Saudi J Biol Sci; 2022 Sep; 29(9):103372. PubMed ID: 35855306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: A world-wide review.
    Wang C; Liu B; Zhang S; Huang N; Zhao T; Lu QB; Cui F
    J Med Virol; 2023 Jan; 95(1):e28118. PubMed ID: 36056540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of the Omicron variant of SARS-CoV-2 in international travelers returning to Venezuela.
    Jaspe RC; Sulbaran Y; Loureiro CL; Moros ZC; Marulanda E; Bracho F; Ramírez NA; Canonico Y; D'Angelo P; Rodríguez L; Castro J; Liprandi F; Rangel HR; Pujol FH
    Travel Med Infect Dis; 2022; 48():102326. PubMed ID: 35395405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heavily mutated Omicron variant puts scientists on alert.
    Callaway E
    Nature; 2021 Dec; 600(7887):21. PubMed ID: 34824381
    [No Abstract]   [Full Text] [Related]  

  • 38. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines.
    Araf Y; Akter F; Tang YD; Fatemi R; Parvez MSA; Zheng C; Hossain MG
    J Med Virol; 2022 May; 94(5):1825-1832. PubMed ID: 35023191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern.
    Paz M; Aldunate F; Arce R; Ferreiro I; Cristina J
    Virus Res; 2022 Jun; 314():198753. PubMed ID: 35331836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.